EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Microglia sense astrocyte dysfunction and prevent disease progression in an Alexander disease model

Kozo Saito, Eiji Shigetomi, Youichi Shinozaki, Kenji Kobayashi, Bijay Parajuli, Yuto Kubota, Kent Sakai, Miho Miyakawa, Hiroshi Horiuchi, Junichi Nabekura, Schuichi Koizumi

Brain · 2024

DOI: 10.1093/brain/awad358 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, 2024. Verfasst von Kozo Saito und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropharmacology, Interdisciplinary Graduate School of Medicine, University of Yamanashi, Yamanashi 409-3898, Japan. Hauptthemen laut MEDLINE: Alexander Disease. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: JSPS KAKENHI, AMED-CREST, OPERA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alexander disease (AxD) is an intractable neurodegenerative disorder caused by GFAP mutations. It is a primary astrocyte disease with a pathological hallmark of Rosenthal fibres within astrocytes. AxD astrocytes show several abnormal phenotypes. Our previous study showed that AxD astrocytes in model mice exhibit aberrant Ca2+ signals that induce AxD aetiology. Here, we show that microglia have unique phenotypes with morphological and functional alterations, which are related to the pathogenesis of AxD. Immunohistochemical studies of 60TM mice (AxD model) showed that AxD microglia exhibited highly ramified morphology. Functional changes in microglia were assessed by Ca2+ imaging using hippocampal brain slices from Iba1-GCaMP6-60TM mice and two-photon microscopy. We found that AxD microglia showed aberrant Ca2+ signals, with high frequency Ca2+ signals in both the processes and cell bodies. These microglial Ca2+ signals were inhibited by pharmacological blockade or genetic knockdown of P2Y12 receptors but not by tetrodotoxin, indicating that these signals are independent of neuronal activity but dependent on extracellular ATP from non-neuronal cells. Our single-cell RNA sequencing data showed that the expression level of Entpd2, an astrocyte-specific gene encoding the ATP-degrading enzyme NTPDase2, was lower in AxD astrocytes than in wild-type astrocytes. In situ ATP imaging using the adeno-associated virus vector GfaABC1D ATP1.0 showed that exogenously applied ATP was present longer in 60TM mice than in wild-type mice. Thus, the increased ATP level caused by the decrease in its metabolizing enzyme in astrocytes could be responsible for the enhancement of microglial Ca2+ signals. To determine whether these P2Y12 receptor-mediated Ca2+ signals in AxD microglia play a significant role in the pathological mechanism, a P2Y12 receptor antagonist, clopidogrel, was administered. Clopidogrel significantly exacerbated pathological markers in AxD model mice and attenuated the morphological features of microglia, suggesting that microglia play a protective role against AxD pathology via P2Y12 receptors. Taken together, we demonstrated that microglia sense AxD astrocyte dysfunction via P2Y12 receptors as an increase in extracellular ATP and alter their morphology and Ca2+ signalling, thereby protecting against AxD pathology. Although AxD is a primary astrocyte disease, our study may facilitate understanding of the role of microglia as a disease modifier, which may contribute to the clinical diversity of AxD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alexander DiseaseMiceAnimalsGlial Fibrillary Acidic ProteinAstrocytesMicrogliaClopidogrelCalciumDisease ProgressionAdenosine Triphosphate

Stichwörter der Autor:innen

Alexander diseaseastrocyte-microglia interactionsmicroglial ca2+ signalsingle-cell RNA sequencingtwo-photon imaging

Substanzen

Glial Fibrillary Acidic ProteinClopidogrelCalciumAdenosine Triphosphate

Autor:innen und Institutionen

  • Department of Neuropharmacology, Interdisciplinary Graduate School of Medicine, University of Yamanashi, Yamanashi 409-3898, Japan.
  • GLIA Center, University of Yamanashi, Yamanashi 409-3898, Japan.
  • Division of Homeostatic Development, National Institute for Physiological Sciences, National Institutes of Natural Sciences, Aichi 444-8585, Japan.

Förderung

  • JSPS KAKENHI
  • AMED-CREST
  • OPERA

Zitieren

APA

Saito, K., Shigetomi, E., Shinozaki, Y., Kobayashi, K., Parajuli, B., Kubota, Y., Sakai, K., Miyakawa, M., Horiuchi, H., Nabekura, J., & Koizumi, S. (2024). Microglia sense astrocyte dysfunction and prevent disease progression in an Alexander disease model. Brain. https://doi.org/10.1093/brain/awad358

Vancouver

Saito K, Shigetomi E, Shinozaki Y, Kobayashi K, Parajuli B, Kubota Y, et al. Microglia sense astrocyte dysfunction and prevent disease progression in an Alexander disease model. Brain. 2024. doi:10.1093/brain/awad358

BibTeX
@article{Saito2024,
  author = {Saito, Kozo and Shigetomi, Eiji and Shinozaki, Youichi and Kobayashi, Kenji and Parajuli, Bijay and Kubota, Yuto and Sakai, Kent and Miyakawa, Miho and Horiuchi, Hiroshi and Nabekura, Junichi and Koizumi, Schuichi},
  title = {Microglia sense astrocyte dysfunction and prevent disease progression in an Alexander disease model},
  journal = {Brain},
  year = {2024},
  doi = {10.1093/brain/awad358}
}
Kostenlos starten →